Loading
Stephanie Bewick

Stephanie Bewick

Chief Business Officer, Accession Therapuetics
United Kingdom
Stephanie has over 20 years’ experience in business development with a proven track record in negotiation of in- and out-licensing deals, setting business strategy, and raising capital in biotech companies including Mayne Pharma, Summit Therapeutics and Destiny Pharma. Stephanie has experience from the research up to Phase 3 development and has worked with multi-cultural teams in Europe, US and Asia Pacific. She has a PhD from University of Bristol and a BSc (Hons) from the University of Edinburgh.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS